To the Editor:

In a recent issue, Lonnemann *et al.*[@bib1] purport to demonstrate that "timely" referral to nephrology slows progression of early to late chronic kidney disease (CKD) and reduces cost. We find several areas of concern in the conduct of the study. Validation of the use of administrative codes to document CKD progression is lacking. Indeed, as shown in Table 3 in the article, nearly as many persons had a regression of CKD stage from 2009 to 2010 as had a progression of disease. In the "timely referral" group, both exposure to nephrology care and the outcome of interest, CKD progression, were ascertained concurrently, so that there is no way to know whether the outcome occurred before or after the exposure. Beyond rudimentary matching by age and gender, the study does not adjust for several key factors that may influence CKD progression,[@bib2], [@bib3], [@bib4] several of which are listed in Table 5 in the article. The major issue, however, is one of ecological fallacy: it is not that exposure to a nephrologist has a particular salutary effect but, rather, that persons who tend to be healthier, and have slowly progressive CKD, have the opportunity to seek nephrology care. In contrast, persons who experience disease progression or require renal replacement therapy as the result of catastrophic illness do not have that opportunity. Higher subsequent health care use and mortality risk would be expected for the latter group. Further work would be needed to determine whether very early nephrology referral should be a policy objective.
